The International Map of Axial Spondyloarthritis (IMAS) Survey

Help researchers better understand the impact of axial spondyloarthritis ([axSpA] including ankylosing spondylitis and non-radiographic axial spondyloarthritis) on those living with it!

This online survey will explore the effect of axSpA on relationships, career and work, day-to-day function, mental health, and overall quality of life, as well as examine barriers to early diagnosis and effective treatment.

Give axSpA a stronger voice and describe its impact on YOUR daily experiences!

 Study design

A 30-minute online survey to be completed by respondents. The questions in this survey are tailored to the United States to reflect the specifics in the U.S. health care system, and the treatments available.

Who is eligible to take part?

U.S. residents aged 18 years or older, with a diagnosis of axSpA (ankylosing spondylitis or non-radiographic axial spondyloarthritis). Screening questions will be used to determine eligibility for each respondent to the survey.

For questions about:

• • The U.S. study, please contact Sandra Flierl at flierl@ipsos.com
  • Your rights as a study participant, please contact Pearl IRB at 1-317-899-9341 between 8:00 am and 5:00 pm
  • The IMAS study in countries outside of the United States: please contact the Axial Spondyloarthritis International Federation (ASIF) at office@asif.info

 IRB Approval: #21-IPSO-144

This study is sponsored by Novartis Pharma AG.

START THE SURVEY NOW!